96898 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Urine Markers and Methods for Detection of Bladder Cancer and Treatment Thereof
#902Designed ankyrin repeat domains with altered surface residues
#903Innocuous, structured scaffolds for structure-based amyloid disease vaccines and antigens
#904Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
#905Method for accelerating nerve regeneration
#906Drug-controlled systems and uses thereof
#907Peptides and compositions for use in cosmetics
#908Lym-1 and Lym-2 antibody compositions and improved car constructs
#909NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#910PEPTIDE DIRECTED PROTEIN KNOCKDOWN
#911Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions
#912N-terminal capping modules of ankyrin repeat domains
#913Immunoregulatory agent
#914TRANSFERRIN RECEPTOR TARGETING PEPTIDES
#915SALMONELLA VACCINE FOR THE TREATMENT OF CORONAVIRUS
#916AGENTS FOR PROMOTING TISSUE REGENERATION BY RECRUITING BONE MARROW MESENCHYMAL STEM CELLS AND/OR PLURIPOTENT STEM CELLS INTO BLOOD
#917Method of treating osteoarthritis
#918Peptide for enhancing expression efficiency of target protein, and fusion protein comprising same
#919Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia
#920Peptides and combination of peptides for use in immunotherapy against various tumors
#921Peptides and combination of peptides for use in immunotherapy against various tumors
#922ENGINEERED T-CELL MODULATING MOLECULES AND METHODS OF USING SAME
#923Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist
#924COMPOSITIONS AND METHODS OF TREATMENT OF VISION LOSS THROUGH GENERATION OF ROD PHOTORECEPTORS FROM MÜLLER GLIAL CELLS
#925Peptides and combination of peptides for use in immunotherapy against various tumors
#926VIRALLY EXPRESSED INHIBITORS OF PDZ DOMAINS, SUCH AS PICK1 AND USES THEREOF
#927Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for treatment of colorectal cancer
#928Stabilized influenza hemagglutinin stem region trimers and uses thereof
#929Method of reducing neuronal microtubule binding protein Tau (Tau) levels
#930HETERODIMERIC PROTEINS FOR MODULATING GAMMA DELTA T CELLS
#931METHODS OF MODULATING RNA
#932METHODS FOR ELICITING SELECTIVE HUMORAL RESPONSES
#933Pharmaceutical compositions and methods targeting Wnt pathway proteins
#934INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#935Repair of UV-induced DNA lesions
#936Peptides and combination of peptides for use in immunotherapy against various tumors
#937Peptides and combination of peptides for use in immunotherapy against various tumors
#938Animal-free dietary collagen
#939Isoform Nell-1 peptide
#940IMMUNOMODULATORY CELLS AND USES THEREOF
#941MODIFICATION OF RNA-RELATED ENZYMES FOR ENHANCED PRODUCTION
#942Peptides and combination of peptides for use in immunotherapy against various tumors
#943Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof
#944Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated Diseases
#945Methods of treating mitochondrial disorders
#946Peptide Possessing Mesenchymal-Stem-Cell Mobilizing Activity
#947Heat Shock Protein-Binding Peptide Compositions And Methods Of Use Thereof
#948COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#949Peptides and combination of peptides for use in immunotherapy against various tumors
#950Multimeric Hybrid Fc Proteins for Replacement of IVIG
#951EXTRACELLULAR MATRIX PROTEIN COMPOSITIONS AND METHODS FOR TREATING WOUNDS
#952Voltage-Gated Calcium Channel Auxilliary Subunit Alpha 2 Delta and Uses Thereof
#953A METHOD FOR TREATING AN AUDITORY NEUROPATHY SPECTRUM DISORDER
#954SYNTHETIC BI-EPITOPE COMPOUND
#955Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
#956Peptides and combination of peptides for use in immunotherapy against various tumors
#957Compositions and methods for diagnosing and/or treating kidney injury
#958BISTABLE TYPE II OPSINS AND USES THEREOF
#959D-domain containing polypeptides and uses thereof
#960Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3)
#961Fusion-proteins based on human ferritin and protease-cleavable peptides and their use as chemotherapeutics carriers
#962Budding yeast with human chromatin
#963Peptide probe for recognition of G-quadruplex and use thereof in detection of G-quadruplex in cell
#964Polypeptides binding to human complement C5
#965D-domain containing polypeptides and uses thereof
#966Codon optimized otoferlin AAV dual vector gene therapy
#967Frataxin expression constructs having engineered promoters and methods of use thereof
#968RASOPATHY TREATMENT
#969SH3 domain derivatives
#970Peptides and combination of peptides for use in immunotherapy against various tumors
#971Peptides and combination of peptides for use in immunotherapy against various tumors
#972Peptides and combination of peptides for use in immunotherapy against various tumors
#973Peptides and combination of peptides for use in immunotherapy against various tumors
#974Peptides and combination of peptides for use in immunotherapy against various tumors
#975METHODS AND COMPOSITIONS COMPRISING TAU OLIGOMERS
#976MULTISPECIFIC PROTEINS
#977NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED TUMOUR ANTIGEN
#978COMPOSITIONS AND METHODS FOR TREATMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
#979Circular tandem repeat proteins
#980Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses
#981Compositions and methods for treating or preventing fibrosis
#982NON-CANONICAL SWI/SNF COMPLEX AND USES THEREOF
#983CELLS AND METHODS FOR IMPROVED IMMUNOTHERAPY
#984Inhibitors of T-cell activation
#985TISSUE-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES
#986COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY
#987COMPOSITIONS FOR DISEASE TREATMENT
#988USE OF A SMALL NATIVE PEPTIDE ACTIVATOR OF SERCA PUMP FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS CHARACTERIZED BY CYTOSOLIC CALCIUM OVERLOAD
#989WNT/SFRP COMPLEXES, WNT-CONTAINING COMPOSITIONS, WNT-EXPRESSING CELLS, AND METHODS OF MAKING, PURIFYING, AND USING SAME
#990DNA binding proteins and uses thereof
#991Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders
#992METHOD AND SYSTEM FOR TREATING CANCER UTILIZING TINAGL1
#993SNAP-25 REPORTER CONSTRUCTS AND METHODS OF USING THE SAME
#994VERSATILE DISPLAY SCAFFOLDS FOR PROTEINS
#995Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#996Alkaline phosphatase fusion antibody and method for producing the same, and immunoassay method
#997MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#998GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR
#999HTT REPRESSORS AND USES THEREOF
#1000Self Replicating RNA System
#1001Compositions and methods for treating non-age-associated hearing impairment in a human subject
#1002NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1
#1003PROTOXIN-II VARIANTS AND METHODS OF USE
#1004Modification and compositions of human secretoglobin proteins
#1005Therapeutic peptides
#1006SYNP78 (PROA27), A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN RETINAL GANGLION CELLS
#1007Methods and compositions for regenerating tissues
#1008Molecules for organelle-specific protein delivery
#1009SYNP194 (PROB15), A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN RETINAL GANGLION CELLS
#1010Peptides and combination of peptides for use in immunotherapy against various cancers
#1011Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such
#1012PEPTIDE IMMUNOGEN CONSTRUCTS DIRECTED AGAINST DIPEPTIDE REPEAT PROTEINS FROM C9ORF72
#1013Ankyrin repeat binding proteins and their uses
#1014Gene therapy vector for treating retinitis pigmentosa disease
#1015Peptides and combination of peptides for use in immunotherapy against various cancers
#1016METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#1017Use of regulatory T cell-specific surface protein LRIG-1
#1018VEGF antagonist formulations suitable for intravitreal administration
#1019HMGB1 PROTEIN DERIVATIVES FOR THE REMOVAL OF BIOFILMS
#1020DIRECTED PSEUDOURIDYLATION OF RNA
#1021Granulysin, method of obtaining same, and uses
#1022Miniaturized dystrophins having spectrin fusion domains and uses thereof
#1023HETEROCYCLIC COMPOUND
#1024Compositions for treatment of vascular disease
#1025Compositions and materials for regeneration of skeletal muscle
#1026GENE THERAPY FOR OCULAR DISORDERS
#1027Methods of treating non-syndromic sensorineural hearing loss
#1028RECOMBINANT VIRAL VECTORS AND NUCLEIC ACIDS FOR PRODUCING THE SAME
#1029CYTOTOXIC MOLECULES RESPONSIVE TO INTRACELLULAR LIGANDS FOR SELECTIVE T CELL MEDIATED KILLING
#1030METHODS AND COMPOSITIONS FOR TREATING A RESPIRATORY DISEASE
#1031Sensors and assays for ubiquitin or ubiquitin-like proteins
#1032Means and method for producing and purifying viral vectors
#1033HAEMATOPOIETIC STEM CELL-GENE THERAPY FOR WISKOTT-ALDRICH SYNDROME
#1034ARRDC1-MEDIATED MICROVESICLES (ARMMS) AND USES THEREOF
#1035Activin type 2 receptor binding proteins methods of making them
#1036METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES
#1037Non-human animals models of retinoschisis
#1038Compositions and methods related to the methylation of histone H1.0 protein
#1039Multiple rapid detection kits and methods for various viruses
#1040TARGETED PROTEIN DEGRADATION TO ATTENUATE ADOPTIVE T-CELL THERAPY ASSOCIATED ADVERSE INFLAMMATORY RESPONSES
#1041ANTIBODY THAT BINDS MURINE WISE PROTEIN
#1042CELL-PENETRATING PEPTIDE DIMERS, METHOD FOR PREPARING THE SAME, AND CARGO DELIVERY SYSTEM USING THE SAME
#1043Fascin-2 (FSCN2) Variants And Uses Thereof
#1044MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
#1045SYNP162, a promoter for the expression of genes
#1046Importation of mitochondrial protein by an enhanced allotopic approach
#1047CANCER TARGETS AND USES THEREOF
#1048ALLERGY ANTIGEN AND EPITOPE THEREOF
#1049Peptides and combination of peptides for use in immunotherapy against various cancers
#1050Peptides and combination of peptides for use in immunotherapy against various cancers
#1051PH20 polypeptide variants, formulations and uses thereof
#1052Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
#1053Tumour immunogen, preparation method therefor, and application
#1054Encryption device and operation method thereof
#1055Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders
#1056IMMUNE-MEDIATED CORONAVIRUS TREATMENTS
#1057Peptides and combination of peptides for use in immunotherapy against various cancers
#1058Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1059IDENTIFICATION, SELECTION AND USE OF HIGH CURATIVE POTENTIAL T CELL EPITOPES
#1060PH20 polypeptide variants, formulations and uses thereof
#1061Alpha-synuclein substrates and methods for making and using the same
#1062Animal-free dietary collagen
#1063Extended recombinant polypeptides and compositions comprising same
#1064KIDNEY DISEASE TARGETS AND USES THEREOF
#1065RECOMBINANT GRP94 CHAPERONES AND METHODS OF USING THE SAME TO MODULATE GLYCOSYLATION IN FUSION PROTEINS
#1066NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#1067Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#1068PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS
#1069Anti-TrkB agonist antibodies binding to D1 domain of TrkB
#1070PROTEIN-BASED MICELLES FOR THE DELIVERY OF HYDROPHOBIC ACTIVE COMPOUNDS
#1071Cancer vaccines and methods of treatment using the same
#1072TARGETED EXPANSION OF QA-1-PEPTIDE-SPECIFIC REGULATORY CD8 T CELLS TO AMELIORATE ARTHRITIS
#1073LAMP CONSTRUCTS COMPRISING ALLERGENS
#1074Apelin polypeptides
#1075Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM system
#1076Peptides for the treatment of resorptive bone disease
#1077METHOD FOR PRODUCING ORGANIC COMPOUND-ENCAPSULATING FERRITIN
#1078Regulatory T cell epitopes, compositions and uses thereof
#1079Human Anti-Tau Antibodies
#1080MODIFIED MITOCHONDRIA AND USE THEREOF
#1081Method of managing joint pain
#1082Regulatory T cell epitopes, compositions and uses thereof
#1083Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same
#1084Method of managing joint pain
#1085MANIPULATION OF EIF3 TO MODULATE REPEAT ASSOCIATED NON-ATG (RAN) TRANSLATION
#1086Cytosine to guanine base editor
#1087Core domain of annexins and uses thereof in antigen delivery and vaccination
#1088METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION
#1089Proteins for the treatment of epithelial barrier function disorders
#1090Intrathecal delivery of recombinant adeno-associated virus 9
#1091Biocatalysts for ezetimibe synthesis
#1092Use of recombinant human secretory DDRGK1
#1093INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9
#1094Expression cassette with a SynP160 promoter
#1095Bi-specific fusion proteins
#1096TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#1097Method and means for diagnosing and treating allergy
#1098EGFR and C-met fibronectin type III domain binding molecules
#1099Fusion proteins comprising an engineered knottin peptide and uses thereof
#1100Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin Receptor
#1101Genetically encoded system for constructing and detecting biologically active agents
#1102Detection of Optimal Recombinants Using Fluorescent Protein Fusions
#1103KIT FOR REPARING FBN1T7498C MUTATION, COMBINATION FOR MAKING AND REPAIRING MUTATION, AND METHOD OF REPAIRING THEREOF
#1104ADENO-ASSOCIATED VIRAL VECTOR-MEDIATED GENE THERAPY FOR TREATING FRAGILE X-ASSOCIATED DISORDERS
#1105COMPOSITIONS AND METHODS FOR INCREASING BEIGING OF WHITE ADIPOSE TISSUE
#1106EphA2 T-cell epitope agonists and uses therefore
#1107Peptides for targeting LRP6-overexpressed cells
#1108MODULATED CAS-INHIBITORS
#1109SUMO AND USES THEREOF
#1110TEAR LIPOCALIN MUTEINS BINDING IL-4 R ALPHA
#1111METHOD FOR PRODUCING FUSION PROTEIN, NUCLEIC ACID, CELL, AND ANIMAL
#1112Peptides and combination of peptides for use in immunotherapy against various tumors
#1113Peptides and combination of peptides for use in immunotherapy against various tumors
#1114LONG-ACTING CONJUGATE OF TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST
#1115METHODS AND COMPOSITIONS FOR GENOME ENGINEERING
#1116PROGRANULIN VARIANTS
#1117SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS
#1118DOMINANT NEGATIVE SARM1 MOLECULES AS A THERAPEUTIC STRATEGY FOR NEURODEGENERATIVE DISEASES OR DISORDERS
#1119NON-MEIOTIC ALLELE INTROGRESSION
#1120Biomarker pairs for predicting preterm birth
#1121Programmable assembly of virus composites for receptor-targeted gene delivery
#1122Systems and methods for producing injectable enhanced stem cell exosomes, improved exosomes and methods of use
#1123Membrane-Receiver Complex Therapeutics
#1124Peptides and combination of peptides for use in immunotherapy against various tumors
#1125Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies
#1126SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE
#1127Fusion proteins with specificity for ED-B and long serum half-life for diagnosis or treatment of cancer
#1128Frataxin expression constructs
#1129Modified cascade ribonucleoproteins and uses thereof
#1130Method of treating inflammatory bowel disease
#1131TRUNCATED CARTILAGE-HOMING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF
#1132Fusion proteins for the detection of apoptosis
#1133Antibodies specific for sulfation sites of Wnt pathway proteins
#1134NBP158 and uses thereof
#1135DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR DECREASING VIABILITY OF NEOPLASTIC CELLS
#1136EXOSOME PACKAGING AND TARGETED AUTOPHAGY
#1137Targeting macula densa cells as a new therapeutic approach for kidney disease
#1138Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
#1139ALLOGRAFT TOLERANCE WITHOUT THE NEED FOR SYSTEMIC IMMUNE SUPPRESSION
#1140Therapeutic agents specifically delivered by exosomes for cancer treatment
#1141NON-HUMAN ANIMALS HAVING A HUMANIZED A PROLIFERATION-INDUCING LIGAND GENE
#1142MYC NUCLEIC ACIDS AND USES THEREOF
#1143ANTI-TUMOR COMPOSITION COMPRISING GM-CSF GENE, Flt3L-TRAIL FUSION GENE, shRNA INHIBITING TGF-ß EXPRESSION, AND shRNA INHIBITING HSP EXPRESSION
#1144Peptide conjugates
#1145Manipulating ARID5B expression in immune cells to promote metabolism, survival, and function
#1146TRIPLE FUNCTION ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF C9ORF72 ASSOCIATED DISEASES
#1147ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATMENT OF PROGRANULIN ASSOCIATED NEURODEGENERATIVE DISEASES OR DISORDERS
#1148COMPOSITIONS AND METHODS FOR THE TREATMENT OF STARGARDT DISEASE
#1149Methods of inhibiting integrin α9β1 activity
#1150Peptides for angiogenic therapy
#1151Peptides, hydrogel compositions and methods of use thereof
#1152ICAM-1 targeted fusion enzymes
#1153PEPTIDES DERIVED FROM ACTIN-LIKE PROTEIN 8 (ACTL8)
#1154GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THEREOF
#1155Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glycosylated proteins in prokaryotic cell lysates
#1156COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY, CLEAVABLE PORTION, AND REACTIVE GROUP, OR SALT THEREOF
#1157NPY2 RECEPTOR AGONISTS
#1158Optogenetic induction of neurodegenerative disease pathologies
#1159NNIF and nNIF-related peptides and related methods
#1160TRPV3 agonists for the treatment of skin conditions
#1161Dual IL-2R and IL-7R binding compounds
#1162COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING A FRAGMENT OF HUMAN HEAT SHOCK PROTEIN 90A AS AN ACTIVE INGREDIENT
#1163Fusion protein, and pharmaceutical composition for preventing or treating cancer, containing same
#1164DUAL-AAV VECTOR-BASED SYSTEMS AND METHODS FOR DELIVERING OVERSIZED GENES TO MAMMALIAN CELLS
#1165RECOMBINANT BINDING PROTEINS TARGETING HER2 AND SERUM ALBUMIN, AND THEIR USES
#1166PEPTIDE TAG AND TAGGED PROTEIN INCLUDING SAME
#1167MODULAR ANTIGEN TRANSPORTATION MOLECULES AND USES THEREOF IN ANIMALS
#1168Methods for treating huntington's disease using a polynucleotide encoding a VTFT isoform of a BPIFB4 protein
#1169Adiponectin peptidomimetics for treating ocular disorders
#1170Peptides and conjugates
#1171Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS
#1172De novo designed non-local beta sheet proteins
#1173Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-C
#1174Methods and compositions for targeting polyubiquitin
#1175AMYLIN ANALOGUES
#1176MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#1177Polypeptide-polymer conjugates and methods of use thereof
#1178TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT
#1179BIO-MIMETIC FORMULATION
#1180Engineered hERG channel proteins, vesicles and methods of identifying small molecule pharmacological agents
#1181Methods for measuring small molecule affinity to cereblon
#1182Methods for treatment of cancer comprising TIGIT-binding agents
#1183Intrathecal Delivery of Recombinant Adeno-Associated Virus 9
#1184Preparation of flagellin vaccine adjuvant-based vaccine to induce production of antibody recognizing conformation of antigens, and application thereof
#1185MATERIALS AND METHODS FOR THE TREATMENT OF LEWY BODY DISORDERS
#1186CELL PENETRATING PEPTIDES AND RELATED COMPOSITIONS AND METHODS
#1187IN VIVO PRODUCTION OF PROTEINS
#1188Anti-fungal inhibitors
#1189TREATMENT TARGETING ONCOLOGY AND NEURODEGENERATION
#1190ANTIGENIC PEPTIDES DERIVING FROM SECRETOGRANIN V AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#1191MODIFIED BINDING PROTEINS INHIBITING THE VEGF-A RECEPTOR INTERACTION
#1192METHODS AND COMPOSITIONS OF CYTOTOXIC T CELL DEPLETION
#1193Rodents having a humanized TMPRSS gene
#1194SMARTBAC BACULOVIRUS EXPRESSION SYSTEM AND APPLICATION THEREOF
#1195Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#1196ATF5 peptide variants and uses thereof
#1197Targeted intracellular delivery of large nucleic acids
#1198PEPTIDES FROM PIWIL1
#1199MODULATION OF LIVER GENES
#1200IgG4 Fc fragment comprising modified hinge region